Novel AAV Variants Targeting Schwann Cells

被引：0
|
作者：
Kagiava, Alexia [1 ]
Chen, Xin [2 ]
Casy, Widler [2 ]
Dong, Thomas [2 ]
McCown, Thomas J. [3 ]
Gray, Steven J. [2 ]
Kleopa, Kleopas A. [1 ,4 ]
机构：
[1] Cyprus Inst Neurol & Genet, Neurosci Dept, Nicosia, Cyprus
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX USA
[3] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA
[4] Cyprus Inst Neurol & Genet, Ctr Neuromuscular Disorders, Nicosia, Cyprus
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
170
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [1] Novel AAV variants with improved tropism for human Schwann cells
    Drouyer, Matthieu
    Chu, Tak-Ho
    Labit, Elodie
    Haase, Florencia
    Navarro, Renina Gale
    Nazareth, Deborah
    Rosin, Nicole
    Merjane, Jessica
    Scott, Suzanne
    Cabanes-Creus, Marti
    Westhaus, Adrian
    Zhu, Erhua
    Midha, Rajiv
    Alexander, Ian E.
    Biernaskie, Jeff
    Ginn, Samantha L.
    Lisowski, Leszek
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (02)
  • [2] Directed evolution of novel AAV-capsid variants for efficient and specific targeting of primary human Schwann cells
    Haase, F. D.
    Drouyer, M.
    Chu, T.
    Labit, E.
    Navarro, R. G.
    Ginn, S. L.
    Lisowski, L.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A11 - A11
  • [3] Identification and validation of novel engineered AAV capsid variants targeting human glia
    Giacomoni, Jessica
    Akerblom, Malin
    Habekost, Mette
    Fiorenzano, Alessandro
    Kajtez, Janko
    Davidsson, Marcus
    Parmar, Malin
    Bjorklund, Tomas
    FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [4] Selection and Characterization of AAV Variants for Targeting Osteosarcoma
    Lu, Yuan
    Marsic, Damien
    Levings, Padraic P.
    Wang, Yuan
    VanVliet, Kim
    Guijario, Maria V.
    Dacanay, E. Anthony
    Ling, Chen
    Agbandje-Mckenna, Mavis
    Zolotukhin, Sergei
    Ghivizzani, Steven C.
    MOLECULAR THERAPY, 2014, 22 : S172 - S172
  • [5] Novel AAV Capsids for Enhanced Gene Transfer to the Cerebellum, Spinal Cord, and Schwann Cells
    Chen, Xin
    Dong, Thomas
    Casy, Widler
    Hu, Yuhui
    Chen, Daphne
    McCown, Thomas
    Gray, Steven
    MOLECULAR THERAPY, 2021, 29 (04) : 157 - 157
  • [6] Novel Cinnamaldehyde Derivatives Inhibit Peripheral Nerve Degeneration by Targeting Schwann Cells
    Chun, Yoo Lim
    Park, Ki-Hoon
    Pallavi, Badvel
    Eom, Won-Joon
    Park, Chan
    Huh, Youngbuhm
    Lee, Yeonjoo
    Lee, Jimin
    Kim, Sang Hoon
    Yeo, Seung Geun
    Chung, Hyung-Joo
    Kim, Byeong-Seon
    Jeong, Na Young
    Jung, Junyang
    ANTIOXIDANTS, 2022, 11 (10)
  • [7] Directed evolution identifies novel AAV capsid variants for targeting the canine outer retina following intravitreal delivery
    Byrne, Leah C.
    Visel, Meike
    Dufour, Valerie
    Marinho, Felipe Pompeo
    Aguirre, Gustavo D.
    Beltran, William A.
    Schaffer, David
    Flannery, John Gerard
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [8] Novel AAV Capsids for Intravitreal Delivery: Identifying and Characterizing Novel AAV Variants in Non-Human Primates
    Guerin, Karen
    Geller, Scott
    Flannery, John G.
    Isacoff, Ehud
    Beltran, William A.
    Byrne, Leah C.
    Ozturk, Bilge E.
    Mozayeni, Cyrus
    MOLECULAR THERAPY, 2022, 30 (04) : 557 - 557
  • [9] Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous delivery
    Kagiava, A.
    Richter, J.
    Tryfonos, C.
    Leal-Julia, M.
    Sargiannidou, I.
    Christodoulou, C.
    Bosch, A.
    Kleopa, K. A.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [10] Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous delivery
    A. Kagiava
    J. Richter
    C. Tryfonos
    M. Leal-Julià
    I. Sargiannidou
    C. Christodoulou
    A. Bosch
    K. A. Kleopa
    Scientific Reports, 11
12345